Our Leadership

Bobby has almost 40 years in the pharmaceutical and venture capital business. He is currently Managing Director of Paula and Rodger Riney Foundation, General Partner in Cultivation Capital Life Sciences Fund II and President and CEO of Euclises Pharmaceuticals. He was formerly President and CEO of Coronado Biosciences (NASDAQ: CNDO) where he led the effort to take the company public, prior to that he was VP of oncology at Covidien Pharmaceuticals (now Mallinckrodt), and prior to that he was the executive vice president, research and development, and Chief Scientific Officer at Indevus Pharmaceuticals (NASDAQ: IDEV). He previously held senior drug development positions at DuPont Merck Pharmaceutical Company and Merrell Dow Pharmaceuticals. He serves on the boards of Immunophotonics, Endevica Biosciences and BioVentures. He received his Ph.D. in clinical pharmacy from Purdue University and his B.S. in pharmacy from the University of Arkansas.

Dr. Thomas is a native of Louisiana and practices in his home city of New Orleans. He graduated medical school from Louisiana State University in New Orleans. He finished his residency in Neurological Surgery at Louisiana State University in New Orleans and completed specialized additional training in complex and minimally invasive spinal procedures in Memphis, Tennessee under the direction of Kevin T. Foley, M.D.

He has lectured about spinal procedures on five continents and has had interactions with hundreds of surgeons from around the world. He is recognized as an innovator having been involved in the development and commercialization of many medical devices and technologies. He continues to be active with industry in the latest developments of minimally invasive spine procedures and regenerative medicine technologies so his patients may receive the most advanced spinal care in the world.

Dr. Thomas has been a successful investor in multiple early technology, biotech, and medical device companies with several successful exits. He has led multiple fundraising rounds in the biotech space.

He is the Co-founder, Chairman of the Board, and Medical Director of Crescent City Surgical Centre, a multispecialty surgical hospital serving the greater New Orleans area. Additionally, he serves as Managing member of Southern Brain & Spine, a multispecialty practice focusing on diseases of the brain and spine. He currently serves as a Director for Discgenics Inc., a late stage cell therapy company focusing on the treatment of painful degenerative disc disease of the lumbar spine, and Geneoscopy Inc., a late stage medical diagnostic company for the detection of colorectal cancer. He is a medical adviser for Climbr, Inc and Neurogami Medical. He serves as a Director for Louisiana State University Health Sciences Center Foundation and is on multiple committees for the Foundation. He is Past President of the Louisiana Association of Neurological Surgeons. He has served on multiple committees for the American Association of Neurological Surgeons including as a director for (AANS) Political Action Committee. He is a member of the Louisiana Office of Worker’s Compensation Medical Advisory Committee establishing the treatment guidelines for injured workers in Louisiana. He has lectured and taught courses for multiple professional organizations throughout the world regarding advanced surgical techniques and treatment of patients with spinal disorders.